34 min

Managing MS-Related Cognitive Issues and Depression with Dr. Meghan Beier RealTalk MS

    • Medicine

Cognitive decline and depression are two of the more common invisible symptoms of multiple sclerosis, impacting at least half of all the people living with MS. 
 
My guest is Dr. Meghan Beier, an Assistant Professor of Physical Medicine at the Johns Hopkins University School of Medicine, and a Rehabilitation Neuropsychologist. Dr. Beier specializes in cognitive rehabilitation and neuropsychological assessment and intervention, and she's going to share some specific strategies that you can use to best manage MS-related cognitive problems and depression.
 

 
We're also talking about the newly announced $16 million dollar investment from the National MS Society that will support 50 new MS research initiatives.
 
We'll tell you about a small pilot study that suggests that ketamine may be effective in treating MS fatigue. And if you're contemplating using a CBD product to help manage your MS, you'll want to hear what the FDA discovered when they checked the labels on 147 different CBD products.
 
We're even sharing a new, super-easy way for you to add your rating and review of RealTalk MS (and we'd love it if you would!).


 
We have a lot to talk about! Are you ready for RealTalk MS??!

Announcing the easiest way ever to leave a rating and review for RealTalk MS  :29
The National MS Society just invested $16 million in new MS research  3:14
Study shows that ketamine may be an effective treatment for MS fatigue   5:14
The FDA checked the labels of 147 CBD products  7:37
My Interview with Dr. Meghan Beier  13:31
Share this episode  30:57
Please Support the National MS Society COVID-19 Response Fund  31:16

SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/152

ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: jon@realtalkms.com
Phone: (310) 526-2283
And don't forget to join us in the RealTalk MS Facebook group!

LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
Give RealTalk MS a Rating and Review
National MS Society's Ask An MS Expert Video Replay
What You Need to Know About Coronavirus (COVID-19)
National MS Society's New MS Research Investments
STUDY: Pilot Randomized Active-Placebo-Controlled Trial of Low-Dose Ketamine for the Treatment of Multiple Sclerosis-Related Fatigue
Report to the U.S. House Committee on Appropriations and the U.S. Senate Committee on Appropriations: Sampling Study of the Current Cannabidiol Marketplace to Determine the Extent That Products are Mislabeled or Adulterated
Contact an MS Navigator:
     On The Web
     By Phone: (800) 344-4867
     By Email: contactusnmss@nmss.org
National MS Society COVID-19 Response Fund
Join the RealTalk MS Facebook Group
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 152
Hosted By: Jon Strum
Guests: Dr. Meghan Beier
Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS
Privacy Policy

Cognitive decline and depression are two of the more common invisible symptoms of multiple sclerosis, impacting at least half of all the people living with MS. 
 
My guest is Dr. Meghan Beier, an Assistant Professor of Physical Medicine at the Johns Hopkins University School of Medicine, and a Rehabilitation Neuropsychologist. Dr. Beier specializes in cognitive rehabilitation and neuropsychological assessment and intervention, and she's going to share some specific strategies that you can use to best manage MS-related cognitive problems and depression.
 

 
We're also talking about the newly announced $16 million dollar investment from the National MS Society that will support 50 new MS research initiatives.
 
We'll tell you about a small pilot study that suggests that ketamine may be effective in treating MS fatigue. And if you're contemplating using a CBD product to help manage your MS, you'll want to hear what the FDA discovered when they checked the labels on 147 different CBD products.
 
We're even sharing a new, super-easy way for you to add your rating and review of RealTalk MS (and we'd love it if you would!).


 
We have a lot to talk about! Are you ready for RealTalk MS??!

Announcing the easiest way ever to leave a rating and review for RealTalk MS  :29
The National MS Society just invested $16 million in new MS research  3:14
Study shows that ketamine may be an effective treatment for MS fatigue   5:14
The FDA checked the labels of 147 CBD products  7:37
My Interview with Dr. Meghan Beier  13:31
Share this episode  30:57
Please Support the National MS Society COVID-19 Response Fund  31:16

SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/152

ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: jon@realtalkms.com
Phone: (310) 526-2283
And don't forget to join us in the RealTalk MS Facebook group!

LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
Give RealTalk MS a Rating and Review
National MS Society's Ask An MS Expert Video Replay
What You Need to Know About Coronavirus (COVID-19)
National MS Society's New MS Research Investments
STUDY: Pilot Randomized Active-Placebo-Controlled Trial of Low-Dose Ketamine for the Treatment of Multiple Sclerosis-Related Fatigue
Report to the U.S. House Committee on Appropriations and the U.S. Senate Committee on Appropriations: Sampling Study of the Current Cannabidiol Marketplace to Determine the Extent That Products are Mislabeled or Adulterated
Contact an MS Navigator:
     On The Web
     By Phone: (800) 344-4867
     By Email: contactusnmss@nmss.org
National MS Society COVID-19 Response Fund
Join the RealTalk MS Facebook Group
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 152
Hosted By: Jon Strum
Guests: Dr. Meghan Beier
Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS
Privacy Policy

34 min